Zacks.com Featured Highlights Include TransMedics, Iamgold, Graham and GIII Apparel
CVS Stock Gains From Its Birth Control Prescribing Service Launch
Should You Continue to Retain OMCL Stock in Your Portfolio Now?
(TMDX) - Analyzing TransMedics Gr's Short Interest
Why Shares of TransMedics Stock Plunged This Week
TD Cowen Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $175
TD Cowen analyst Josh Jennings maintains $TransMedics(TMDX.US)$ with a buy rating, and maintains the target price at $175.According to TipRanks data, the analyst has a success rate of 55.5% and a